A new collaboration between global patient-focused NGO The Max Foundation and Novartis is supporting continued access to treatment at no cost for nearly 34,000 patients with chronic myeloid leukaemia (CML), gastrointestinal tumours (GIST) and other rare cancers.
Michael Chicarelli has been named interim CEO of UNM Hospital, with current CEO Steve McKernan retiring in October 2017.
Medical Tourism Training has teamed up with Temos International to improve access to higher quality services for patients accessing global healthcare treatments.
Disarm Therapeutics, which is developing therapeutics to treat patients with neurological diseases, has announced the completion of a US$30-million Series A financing.
New research has uncovered a way to slow viral replication in the gastrointestinal tract of people affected by HIV-AIDS.
Modus Therapeutics AB, a company focused on innovative treatments for patients with sickle cell disease (SCD), has recruited Professor Thomas Knittel as its new CMO.
IRRAS has announced two key appointments to its executive and commercial teams.
International Medical Group (IMG) is providing specialty training for its UK-based in-house flight team to support continuing professional development and revalidation.
A recent survey conducted by ORC International and commissioned by HealthFirst Financial has found that many healthcare providers are not meeting consumers’ need to know costs before treatment.